Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiochemotherapy With Concomitant Deep Regional Hyperthermia in Locally Advanced Rectal Cancer. A Prospective, Randomized Phase III Trial.

NCT06831981 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT06831981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06831981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiochemotherapy With Concomitant Deep Regional Hyperthermia in Locally Advanced Rectal Cancer. A Prospective, Randomized Phase III Trial.
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2024
Completion date
March 1, 2037
Enrollment
264 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer